These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7826906)

  • 41. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
    Hill BT; van der Graaf WT; Hosking LK; de Vries EG; Mulder NH; Whelan RD
    Int J Cancer; 1993 Sep; 55(2):330-7. PubMed ID: 8103761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
    Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC
    J Pharmacol Exp Ther; 2008 Jan; 324(1):95-102. PubMed ID: 17947497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
    Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
    Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
    Toffoli G; Corona G; Gigante M; Boiocchi M
    Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo chemosensitivity of human malignant cystosarcoma phyllodes xenografts.
    Ueyama Y; Abe Y; Ohnishi Y; Sawa N; Hatanaka H; Handa A; Tokuda Y; Yamazaki H; Kijima H; Tamaoki N; Nakamura M
    Oncol Rep; 2000; 7(2):257-60. PubMed ID: 10671667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma.
    Jonsson B; Nilsson K; Nygren P; Larsson R
    Anticancer Drugs; 1992 Dec; 3(6):641-6. PubMed ID: 1363199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
    Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
    Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Derivation and characterisation of a mouse tumour cell line with acquired resistance to cyclosporin A.
    Wright KA; Twentyman PR
    Eur J Cancer; 1993; 29A(3):389-94. PubMed ID: 8104444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
    Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
    Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
    Kim WJ; Kakehi Y; Yoshida O
    Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
    Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
    Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chloroquine resistance in Plasmodium falciparum is not reversed by BIBW-22, a compound reversing the multidrug resistance phenotype in mammalian cancer cells.
    Dieckmann-Schuppert A; Bamberger U; Schwarz RT
    Biochem Pharmacol; 1993 Oct; 46(8):1421-4. PubMed ID: 8240391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
    Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
    Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
    Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
    Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.